Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC).
Clinical trial NCT05201612 · UNKNOWN
Trial details
- NCT number
- NCT05201612
- Sponsor
- Grupo Espanol Multidisciplinario del Cancer Digestivo
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2024-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.